This pattern aligns with observations in Ebola survivors showing persistent decreased MCH or elevated ALT and AST, markers of unresolved cellular injury [25], though SFTS exhibits broader multi-organ involvement. The gene discussed is PMCH; the disease is Ebola hemorrhagic fever.